Annals of Surgical Oncology

, Volume 15, Issue 12, pp 3561–3566 | Cite as

Results After Conservative Treatment of Serous Borderline Tumors of the Ovary with a Micropapillary Pattern

  • Isabelle Laurent
  • Catherine Uzan
  • Sebastien Gouy
  • Patricia Pautier
  • Pierre Duvillard
  • Philippe Morice
Gynecologic Oncology



The aim of this study was to assess the outcomes of patients treated conservatively for a serous borderline ovarian tumor with micropapillary patterns (SBOT-MP).


Retrospective study collecting cases of conservative treatment of SBOT-MP. There are 15 patients treated with conservative management for a stage I (n = 8) or III (n = 7) SBOT-MP. Eight patients underwent a unilateral salpingo-oophorectomy with a contralateral cystectomy, three a unilateral salpingo-oophorectomy, two a cystectomy, and two a bilateral cystectomy. Four patients had stromal microinvasion associated with MP at histological examination of the ovarian tumor. Noninvasive implants were observed in eight patients and invasive implants in one. Three patients had residual disease <1 cm on the peritoneum. One patient received adjuvant chemotherapy.


After a median interval of 63 months (range, 18–120 months), 11 recurrences were observed: six of them exclusively on the ovary, three exclusively on the peritoneum (invasive peritoneal disease in one), and two on the ovary and peritoneum. One of the last two patients succumbed to the recurrence (under the form of invasive adenocarcinoma). The other patients were actually disease free. Five patients achieved eight spontaneous pregnancies.


This study demonstrates that spontaneous pregnancies can be achieved after conservative treatment of SBOT-MP. Nevertheless, as 2/3 of patients had bilateral ovarian involvement at the time of initial management, the recurrence rate is high. However, making definitive conclusions about the safety of conservative surgery is limited by the small sample size. So, further studies are warranted to evaluate conservative management of advanced-stage disease.


Ovarian Tumor Conservative Surgery Borderline Tumor Borderline Ovarian Tumor Peritoneal Implant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Acknowledgments to Lorna Saint Ange for editing the manuscript.


  1. 1.
    Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20:1319–30PubMedCrossRefGoogle Scholar
  2. 2.
    Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20:1331–45PubMedCrossRefGoogle Scholar
  3. 3.
    Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999; 23:397–409PubMedCrossRefGoogle Scholar
  4. 4.
    Winter WE III, Kucera PR, Rodgers W, et al. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002; 100:671–6PubMedCrossRefGoogle Scholar
  5. 5.
    Camatte S, Morice P, Thoury A, et al. Impact of restaging surgery in patients with macroscopic “stage I” ovarian borderline tumors: analysis of a continuous series of 101 cases. Eur J Cancer 2004; 40:1842–9PubMedCrossRefGoogle Scholar
  6. 6.
    Fauvet R, Boccara J, Dufournet C, et al. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 2004; 100:1145–51PubMedCrossRefGoogle Scholar
  7. 7.
    Gottlieb W, Flikker S, Davidson B, et al. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 1998; 82:141–6CrossRefGoogle Scholar
  8. 8.
    Morris RT, Gershenson DM, Silvia EG, et al. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000; 95:541–7PubMedCrossRefGoogle Scholar
  9. 9.
    Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility results after conservative treatment for ovarian borderline tumor. Fertil Steril 2001; 75:92–6PubMedCrossRefGoogle Scholar
  10. 10.
    Tazelaar H, Bostwick D, Ballon S. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985; 66:417–21PubMedGoogle Scholar
  11. 11.
    Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19:2656–64Google Scholar
  12. 12.
    Fauvet R, Poncelet C, Boccara J, et al. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril 2005; 83:284–90PubMedCrossRefGoogle Scholar
  13. 13.
    Morice P. Borderline tumor of the ovary and infertility. Eur J Cancer 2006; 42:149–58PubMedCrossRefGoogle Scholar
  14. 14.
    Changes in definitions of clinical staging for carcinoma of the cervix and ovary. International federation of gynecology and obstetrics. Am J Obstet Gynecol 1987; 156:263–4Google Scholar
  15. 15.
    Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 1988; 62:2212–22PubMedCrossRefGoogle Scholar
  16. 16.
    Prat J, De Nictolis M. Serous borderline tumors of the ovary. A long-term follow-up study of 137 cases including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002; 26:1111–28PubMedCrossRefGoogle Scholar
  17. 17.
    Slomovitz BM, Caputo TA, Gretz HF 3rd, et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002; 26:592–600PubMedCrossRefGoogle Scholar
  18. 18.
    Longacre TA, Mc Kenney JK, Tazelaar HD, et al. Ovarian serous tumors of low malignant potential (borderline tumors). Outcome-based study in 276 patients with long-term (≥5 year) follow-up. Am J Surg Pathol 2005; 29:707–23PubMedCrossRefGoogle Scholar
  19. 19.
    Deavers MT, Gershenson DM, Tortolero-Luna G, et al. Micropapillary and cribiform patterns in ovarian serous tumors of low malignant potential. Am J Surg Pathol 2002; 26:1129–41PubMedCrossRefGoogle Scholar
  20. 20.
    Fain V, Poirot C, Zafrani Y, et al. Feasibility of ovarian cryopreservation in borderline ovarian tumor. 18th Congrès de la Société Française d’Oncologie Gynécologique. Lille. Dec 6–7, 2007Google Scholar
  21. 21.
    Gershenson D, Silva E, Levy L, et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998; 82:1096–103PubMedCrossRefGoogle Scholar
  22. 22.
    Gershenson D, Silva EL, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with non invasive peritoneal implants. Cancer 1998; 83:2157–63PubMedCrossRefGoogle Scholar
  23. 23.
    Morice P, Camatte S, Rey A, et al. Prognostic factors of patients with advanced stage serous borderline tumor of the ovary. Ann Oncol 2003; 14:592–8PubMedCrossRefGoogle Scholar
  24. 24.
    Camatte S, Morice P, Pautier P, et al. Fertility results after conservative treatment of advanced stage serous borderline tumors of the ovary. BJOG 2002; 109:376–80PubMedCrossRefGoogle Scholar
  25. 25.
    Basille C, Olivennes F, Le Calvez J, et al. Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours. Hum Reprod 2006; 21:3241–5PubMedCrossRefGoogle Scholar
  26. 26.
    Fortin A, Morice P, Thoury A, et al. Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril 2007; 87:591–6PubMedCrossRefGoogle Scholar
  27. 27.
    Attar E, Berkman S, Topuz S, et al. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report. Hum Reprod 2004; 9:472–5Google Scholar

Copyright information

© Society of Surgical Oncology 2008

Authors and Affiliations

  • Isabelle Laurent
    • 1
  • Catherine Uzan
    • 1
  • Sebastien Gouy
    • 1
  • Patricia Pautier
    • 1
  • Pierre Duvillard
    • 1
  • Philippe Morice
    • 1
  1. 1.Service de Chirurgie GynécologiqueInstitut Gustave-RoussyVillejuif CedexFrance

Personalised recommendations